Seeing Is Believing
Healthcare - Sector
SUPN is currently covered by 4 analysts with an average price target of $61.4. This is a potential upside of $19.48 (46.47%) from yesterday's end of day stock price of $41.92.
Supernus Pharmaceuticals's activity chart (see below) currently has 135 price targets and 105 ratings on display. The stock rating distribution of SUPN is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 71.93% with an average time for these price targets to be met of 336.63 days.
Highest price target for SUPN is $67, Lowest price target is $55, average price target is $61.4.
Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 09-Jul-2026. First documented stock forecast 12-Mar-2015.
Currently out of the existing stock ratings of SUPN, 2 are a HOLD (33.33%), 4 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Aug-2025
$67
$25.08 (59.83%)
$63
3 months 23 days ago
(09-Jul-2026)
5/9 (55.56%)
$18.25 (37.44%)
83
Buy Since 02-Jan-2023
$65
$23.08 (55.06%)
$45
7 months 9 days ago
(23-Mar-2026)
2/3 (66.67%)
$15.75 (31.98%)
961
$65
$23.08 (55.06%)
$60
8 months 7 days ago
(25-Feb-2026)
4/6 (66.67%)
$8.68 (15.41%)
258
Hold Since 16-Apr-2020
$55
$13.08 (31.20%)
$50
10 months 13 days ago
(19-Dec-2025)
12/13 (92.31%)
$3.52 (6.84%)
268
Buy Since 17-Oct-2025
$65
$23.08 (55.06%)
$65
1 years 15 days ago
(17-Oct-2025)
26/28 (92.86%)
$14.83 (29.56%)
307
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on SUPN (Supernus Pharmaceuticals)?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?